Adopted MeasuresDeveloping MeasuresStanding WorkgroupsResourcesBibliography
Forum on Performance Measures

Chair: John Bartlett M.D. M.P.H. Dr. Bartlett is a Yale and UCLA-trained psychiatrist and manager and a widely respected thinker and visionary on the management and improvement of behavioral healthcare, particularly through the design and development of effective organizational capabilities and infrastructure. He is currently a principal with the Avisa Group, a consulting firm with expertise in policy formulation and program development in behavioral healthcare. In addition to his work with the Avisa Group, Dr. Bartlett currently serves as the executive director of the Forum on Performance Measures in Behavioral Healthcare, a national public policy group devoted to the improvement of treatment and service delivery in behavioral healthcare and prevention through the development and implementation of effective and efficient approaches to accountability and improvement. He also serves as a member of the Policy Committee of the Washington Circle Group, which seeks to improve substance abuse treatment and prevention through the development and dissemination of addiction-specific standards and measures. Dr. Bartlett has extensive experience in both the public and private sectors. Following the completion of his training at UCLA, where he was a Robert Wood Johnson Clinical Scholar and received a MPH in Health Services Management from the UCLA School of Public Health, Dr. Bartlett worked as the Assistant Chief of Staff at the Wadsworth VA Medical Center. In the private sector he has held a number of senior level positions, including that of executive vice president for clinical strategies at Magellan Health Services, currently the nation’s largest managed behavioral healthcare organization; corporate medical director of MCC Behavioral Care, a CIGNA subsidiary; and regional medical director for CIGNA Private Practice Plan, an IPA-type HMO in southern California. In addition, Dr. Bartlett is active at the national level in a variety of roles. These include his past chairmanship of the Quality Improvement and Clinical Services Committee of the American Managed Behavioral Healthcare Association, where for three years he led the development of PERMS, the association's set of performance measures for managed behavioral healthcare programs. Dr. Bartlett also serves as a member of the Behavioral Measures Advisory Panel of the National Committee for Quality Assurance and as a member of the Technical Advisory Panel for the National Quality Forum’s initiative on evidence-based practices for substance use disorder treatment.
Back to top


Doreen Cavanaugh, Ph.D. is a Research Associate Professor at the Health Policy Institute, Georgetown Public Policy Institute, Georgetown University where she is responsible for conducting a program of research and policy analysis in the areas of child and adolescent mental health and substance abuse treatment. She is a Senior Advisor to the Center for Substance Abuse Treatment, (SAMHSA) on adolescent issues addressing the financing and organization of adolescent substance abuse treatment services as well as services for youth with co-occurring disorders. Dr. Cavanaugh is the National Program Director of a 16 state CSAT grant initiative to improve the state infrastructure supporting delivery of treatment for adolescents with substance use and co-occurring disorders. She served as Chairperson of the Financing Workgroup for the Center for Substance Abuse Treatment/Robert Wood Johnson Foundation Summit on Adolescent Substance Abuse Treatment and works on issues including financing treatment and program sustainability. She has completed an extensive analysis of federal policies affecting the delivery of treatment services for adolescents with substance use disorders, and has consulted on the organization and financing of child and adolescent treatment services for states, foundations and national organizations.  Dr. Cavanaugh is Co-chair of a CSAT sponsored committee developing a consumer perception of care survey for adolescents and adults receiving substance abuse treatment. She was the Co-chair of a joint CSAT/CMHS Child/Adolescent Modular Survey Committee and chaired the Washington Circle Subcommittee on Performance Measurement for Care of Adolescents with Substance Use Disorders, a Center for Substance Abuse Treatment supported national group of adolescent substance abuse treatment experts charged with assessing the applicability of the Washington Circle administrative measures to adolescent substance abuse treatment. She serves on a number of related committees including the CMHS sponsored Outcomes Roundtable for Children and Families. Currently Dr. Cavanaugh teaches Mental Health Policy at the Georgetown Public Policy Institute. She taught both Child Welfare Policy and Mental Health Policy at the Boston University School of Social Work for many years.  Dr. Cavanaugh received her Ph.D. in Social Policy from the Heller School for Social Policy and Management, Brandeis University.
Back to top


Mady Chalk, Ph.D. is the Director of the Center for Performance-Based Policy at the Treatment Research Institute (TRI) where she directs collaborations between and among researchers, state and local policy makers, purchasers, elected officials, and treatment providers to develop policy-based strategies for improving delivery of addiction treatment.  Prior to joining TRI, for many years Dr. Chalk was Director of the Division of Services Improvement in the Center for Substance Abuse Treatment (CSAT)/Substance Abuse and Mental Health Services Administration (SAMHSA). Dr. Chalk provided federal leadership for the discretionary grant program at CSAT and for its quality improvement programs, including the Washington Circle Group.  On behalf of CSAT she participated in NiaTx, implementation of the Center’s science-to-service/best practices agenda, its organization and financing studies, and workforce development activities. Dr. Chalk provided leadership for a number of innovative new State-wide programs related to increasing access to alcohol and drug treatment, including a program in general medical settings that provides screening, brief interventions, and referrals to treatment.  Before joining the federal government, Dr. Chalk was Senior Program Officer at the National Academy of Sciences, Institute of Medicine. She received her Ph.D. in Health and Social Policy from the Heller School at Brandeis University.  For 15 years before coming to the Washington area, Dr. Chalk was a faculty member in the Yale University School of Medicine, Department of Psychiatry, and the Director of the Outpatient /Community Services Division of Yale Psychiatric Institute.
Back to top


Deborah Garnick, Ph.D. is a Professor in the Institute for Behavioral Health at The Heller School for Social Policy and Management at Brandeis University and Associate Dean, Academic Personnel.  She received her doctorate in health services research from the School of Hygiene and Public Health at Johns Hopkins University (now the Bloomberg School of Public Health).  During the first ten years of her career, when Dr. Garnick’s research was focused on the quality of hospital services, she explored the issues of hospital market areas, patients’ decisions to select hospitals based on quality, and hospital outcomes.  With colleagues at the University of California, she focused on the relationship of hospital volume and patient outcomes, then a newly emerging area of research. Currently, Dr. Garnick leads the Brandeis team in a collaboration with RTI focused on technical development of the National Outcome Measures (NOMS) for behavioral health in a project funded by the Substance Abuse and Mental Health Administration (SAMHSA). She has led NIH-funded studies focused on exploring the association between substance performance measures and outcomes.  She serves as is the Co-Principal Investigator on studies that involve tracking of drug and alcohol abuse services and mental health services provided by the managed behavioral health care industry.  In addition, she is a member of the Washington Circle Policy Group and leads their workgroup on public sector performance measures for substance abuse.  Dr. Garnick often serves as an expert consultant, most recently as a member of the National Quality Forum’s Substance Use Disorders and Evidence Based-Practices Technical Advisory Panel. Dr. Garnick has published widely the topics of injuries among Medicare and Medicaid beneficiaries, state-level health insurance reform legislation, quality of hospital and ambulatory care, methods of using data collected for administrative purposes for health services research, and performance measures for substance abuse.
Back to top